GET IN TOUCH
Please lodge your grievances with SEBI at https://scores.gov.in
As per PMLA Amendment, linking of Aadhaar with Demat/Trading account is mandatory. All the existing clients shall link their Aadhaar by 31st March 2018. In case the account is not linked within the aforesaid time limit, it will be blocked till Aadhaar Submission.
As per NSDL Circular No: NSDL/POLICY/2017/0022 dated 17th April 2017, all Individual and entity accounts opened from 1st July 2014 to 31st August 2015 has to submit Foreign Account Tax Compliance Act (FATCA) self-declaration (CLICK HERE TO DOWNLOAD ATTACHED FATCA) till 30th April 2017. All the Account Holders who have opened the Demat Account from the period 1st July 2014 to 31st August 2015 are informed to submit the FATCA self declaration to their nearest DP. In case self certification are not provided till 30th April 2017, the Accounts would be blocked.
As per SEBI Letter on collection of Email Ids and Bank Account Details and with Reference to NSDL Circular No: NSDL/POLICY/2017/0009 dated 28th February 2017, it has been observed that Email Ids, Bank Account Details, Mobile Number, SMS Alert of many existing clients are not linked to their Demat Accounts or updated with their latest Bank Account thereby forcing companies to issue printed cheques/warrants and non-receipt of SMS alerts to the client. It is requested to all existing Account Holders to contact their nearest DP for updation of mentioned details in their Demat Accounts.
All existing Individual Demat Account Holders are advised to submit Aadhaar number along with copy of Aadhaar Card to their nearest FSC's.
Entero Healthcare Solutions Ltd |
---|
Registered Office: Plot # I-35 Bldg-B Ind. Area, Phase-I 13/7 Mathura Road, Faridabad - 121003, Haryana |
Phone: 0129-4877300 |
Email: jayant.prakash@enterohealthcare.com |
Website: www.enterohealthcare.com |
Initial public offering of 12,725,244# equity shares of face value of Rs. 10 each (Equity) of Entero Healthcare Solutions Limited (The Company or the Issuer) for cash at a price of Rs. 1,258 per equity share including a share premium of Rs. 1,248 per equity share (the Offer Price) aggregating to Rs. 1600.00# crores (the Offer). The offer comprises of a fresh issue of 7,955,769# equity shares by the company aggregating to Rs. 1000.00# crores (the Fresh Issue) and an offer for sale of 4,769,475# equity shares (the Offered Shares) aggregating to Rs. 600.00# crores (the Offer for Sale), comprising of 470,210# equity shares aggregating to Rs. 59.15# crores by Prabhat Agrawal, 313,472# equity shares aggregating to Rs. 39.44# crores by Prem Sethi, 3,815,580# equity shares aggregating to Rs. 480.00# crores by Orbimed Asia iii Mauritius Limited, 4,401# equity shares aggregating to Rs. 0.55# crores by Chethan M.P., 1,320# equity shares aggregating to Rs. 0.17# crores by Deepesh T. Gala, 8,802# equity shares aggregating to Rs. 1.11# crores by Hemant Jose Barros, 4,401# equity shares aggregating to Rs. 0.55# crores by Hemant Jaggi, 2,201# equity shares aggregating to Rs. 0.28# crores by K.R.V.S. Varaprasad, 39,610# equity shares aggregating to Rs. 4.98# crores by K.E. Prakash, 1,320# equity shares aggregating to Rs. 0.17# crores by Lavu Sahadev, 12,103# equity shares aggregating to Rs. 1.52# crores by Manoj K Sanghani, 8,802# equity shares aggregating to Rs. 1.11# crores by Millennium Medicare Private Limited, 2,201# equity shares aggregating to Rs. 0.28# crores by K. Naveen Kumar Gupta, 42,250# equity shares aggregating to Rs. 5.32# crores by Novacare Drug Specialities Private Limited, 15,074# equity shares aggregating to Rs. 1.90# crores by Petros Diamantides, 13,203# equity shares aggregating to Rs. 1.66# crores by Prashanth Ravindrakumar, 1,102# equity shares aggregating to Rs. 0.14# crores by Suraj Prakash Atreja, 1,320# equity shares aggregating to Rs. 0.17# crores by Venkata Ramana Siva Kumar Yanamadala, 12,103# equity shares aggregating to Rs. 1.52# crores by Vikramaditya Ambre (collectively the Selling Shareholders) (the Offer for Sale, and together with the fresh issue, the Offer). The offer will constitute 29.25%# of the post-offer paid-up equity share capital of the company. The offer included a reservation of 70,237# equity shares, aggregating to Rs. 8.00# crores (constituting 0.16%# of the post-offer paid-up equity share capital), for subscription by eligible employees (Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as the Net Offer. The offer and the net offer constitute 29.25%# and 29.09%#, respectively, of the post-offer paid-up equity share capital of the company. The company, in consultation with the book running lead managers, offered a discount of 9.46% to the offer price to eligible employees bidding in the employee reservation portion (Employee Discount). #Subject to finalisation of basis of allotment The face value of equity shares is Rs. 10 each. The offer price is 125.80 times the face value of the equity shares. |
Issue | Money Payable On | ||
---|---|---|---|
Opens On | Closes On | Application | Allotment |
09-Feb-2024 | 13-Feb-2024 | ₹ 1,258.00 | ₹ 0.00 |
Minimum Application for shares in Nos : 11 Further Multiples of : 11 | ||
---|---|---|
(₹)Cr. | Lead Managers to the Issue | |
Project Cost | 951.20 | Dam Capital Advisors Ltd |
Project Financed through Current Offer | 1,600.00 | |
Post Issue Equity Share Capital | 43.50 | |
Issue Price | ₹1,258.00 |
Projects |
---|
Repayment/prepayment in full or part of certain borrowings availed by the company and its subsidiaries |
Funding the long term working capital requirements |
General corporate purposes |
Pursuing inorganic growth intiatives through acquisitions |
Promoted By |
---|
Prabhat Agrawal |
Prem Sethi |
Orbimed Asia III Mauritius Ltd |
Listing At |
---|
BSE |
NSE |
Registrar to the Issue |
---|
Link Intime India Pvt Ltd |
INDIAN INDICES
83,184.80 236.57 (0.29%)
25,415.80 38.25 (0.15%)
GLOBAL INDICES
83.95 -0.07 (-0.08%)
17,573.30 -54.76 (-0.31%)
18013.16 353.14(2.00%)